• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Steve Delity - Articles and news items

Rapid Micro Biosystems Logo

Rapid Micro Biosystems secures $32.6 million in series B financing

News, Supplier news / 26 June 2013 / Rapid Micro Biosystems

Rapid Micro Biosystems announced that it has raised $32.6 million in series B financing…

Rapid Micro Biosystems Logo

Rapid Micro Biosystems announces the 2013 availability of Growth Direct™ Systems

News, Supplier news / 16 April 2012 / Rapid Micro Biosystems

New applications improve the efficiency of microbial quality control processes…

Under the microscope: Steve Delity

Issue 4 2011 / 31 August 2011 / Steve Delity, CEO, Rapid Micro Biosystems

Rapid Micro Biosystems is a privately owned, venture backed company with headquarters in Bedford, Massachusetts. Since launching its GrowthDirect™ System in 2008, the company has now moved into Europe with the opening of its new demo centre in Darmstadt, Germany in June 2011. So, how does CEO Steve Delity view the current situation in the pharmaceutical industry? “The power of pharmaceutical research and development is so massive that there will always be blockbusters, but will we see the prevalence, the frequency, the number of blockbusters we’ve had in the past? It’s a more efficient deployment of resources to take known drugs and look at whether it’s possible to increase their efficacy or decrease the side effects. The hunt for the next big blockbuster will always be there, but you can spend a lot of money and come up with nothing in the end, which is a huge risk.”

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +